ANTM
Elevance Health Inc.
Set alert
52-week range unavailable
- Open
- 469.53
- Prev close
- 482.58
- Mkt cap
- 116.34B
- Vol
- 1.27M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 1.08%
More statistics
- Low
- 466.74
- High
- 485.75
- Forward P/E
- 14.86
- Beta
- 0.97
- Short ratio
- 2.00
- Inst. own
- 93.43%
- Dividend
- 5.12
- Ex-div date
- Jun 8, 2022
- Earnings
- Jul 20, 2022
- 50-d avg
- 489.26
- 200-d avg
- 456.10
- 1y target
- 565.23
Key statistics
- Market cap
- 116.34B
- Enterprise value
- 104.26B
- Trailing P/E
- 18.99
- Forward P/E
- 14.86
- PEG ratio
- 1.31
- Price / sales
- 0.81
- Price / book
- 3.23
- EPS (TTM)
- 25.41
- Beta
- 0.97
- Dividend yield
- 1.08%
- Payout ratio
- 18.38%
- Profit margin
- 4.32%
- Revenue (TTM)
- 144.35B
- Revenue growth
- 17.60%
- Free cash flow
- 5.41B
- Total cash
- 34.04B
- Total debt
- 24.19B
- Return on equity
- 17.79%
- Shares outstanding
- 241.08M
- Short % of float
- 0.94%
- 50-day average
- 489.26
- 200-day average
- 456.10
Analyst view
Consensus: buy
- Target (low)
- 335.00
- Target (mean)
- 565.23
- Target (high)
- 642.00
- Strong buy7
- Buy4
- Hold8
- Sell0
- Strong sell0
Next earnings
Jul 20, 2022
Expected Jul 20, 2022. Consensus EPS estimate 7.73.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jul 20, 2022 | Jun 1, 2022 | 7.73 | — | — | — |
| Apr 20, 2022 | Mar 1, 2022 | 7.81 | — | — | — |
| Jan 26, 2022 | Dec 1, 2021 | 5.11 | — | — | — |
| Oct 20, 2021 | Sep 1, 2021 | 6.35 | — | — | — |
| Jul 21, 2021 | Jun 1, 2021 | 6.34 | — | — | — |
| Apr 21, 2021 | Mar 1, 2021 | 6.86 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 22, 2022 | Morgan Stanley | down | Overweight | Equal-Weight |
| Jun 17, 2022 | Loop Capital | init | — | Buy |
| May 25, 2022 | Wells Fargo | main | — | Overweight |
| Apr 25, 2022 | BMO Capital | main | — | Outperform |
| Apr 22, 2022 | Deutsche Bank | main | — | Buy |
| Apr 21, 2022 | Morgan Stanley | main | — | Overweight |
About Elevance Health Inc.
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as pharmacy benefits management, dental, vision, life and disability insurance benefits, and analytics-driven personal health care. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2021, it served 45 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- antheminc.com
News
- Stocks That Hit 52-Week Highs On Thursday
- Earnings Scheduled For January 26, 2022
- Stocks That Hit 52-Week Highs On Monday
- Stocks That Hit 52-Week Highs On Friday
- Stocks That Hit 52-Week Highs On Thursday
- Stocks That Hit 52-Week Highs On Tuesday
- Stocks That Hit 52-Week Highs On Monday
- Stocks That Hit 52-Week Highs On Friday
- Stocks That Hit 52-Week Highs On Wednesday
- Stocks That Hit 52-Week Highs On Thursday
Your note
Sign in to keep a note on ANTM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CLARK R KERRY | Director | Stock Award(Grant) | May 17, 2022 | 8,194 |
| DEVORE SUSAN D | Director | Stock Award(Grant) | May 17, 2022 | 856 |
| DIXON ROBERT L JR | Director | Sale | Jun 5, 2022 | 9,491 |
| HAY LEWIS III | Director | Stock Award(Grant) | May 17, 2022 | 10,061 |
| JALLAL BAHIJA | Director | Stock Award(Grant) | May 17, 2022 | 3,342 |
| KENDRICK CHARLES MORGAN JR | Officer | Sale | Jun 8, 2022 | 14,529 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.92% | 21,505,858 | 10.38B | Mar 30, 2022 |
| Vanguard Group, Inc. (The) | 8.62% | 20,772,895 | 10.02B | Mar 30, 2022 |
| State Street Corporation | 4.41% | 10,628,193 | 5.13B | Mar 30, 2022 |
| Wellington Management Group, LLP | 4.20% | 10,129,421 | 4.89B | Mar 30, 2022 |
| Price (T.Rowe) Associates Inc | 3.63% | 8,755,851 | 4.23B | Mar 30, 2022 |
| FMR, LLC | 2.85% | 6,879,028 | 3.32B | Mar 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.89% | 6,961,455 | 3.36B | Mar 30, 2022 |
| Vanguard 500 Index Fund | 2.20% | 5,311,685 | 2.56B | Mar 30, 2022 |
| Vanguard Specialized-Health Care Fund | 1.50% | 3,626,240 | 1.75B | Jan 30, 2022 |
| SPDR S&P 500 ETF Trust | 1.09% | 2,625,738 | 1.27B | May 30, 2022 |
| Fidelity 500 Index Fund | 1.05% | 2,540,006 | 1.23B | Apr 29, 2022 |
| Vanguard/Wellington Fund Inc. | 1.04% | 2,512,768 | 1.21B | Feb 27, 2022 |